What smart money is saying about WuXi Biologics (Cayman) Inc.
1 fund in our archive has pitched WuXi Biologics (Cayman) Inc. — most recently Artisan Sustainable Emerging Markets Strategy in December 2025.
WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.
Position history
Between Q4 2025 and Q2 2026, 1 fund letter reported a position in WuXi Biologics (Cayman) Inc. — 1 trimmed or exited.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 1 | 0 |
| Q4 2025 | 0 | 0 | 0 | 1 |
Fund activity · 1 position · 1 move
- June 2026
“During the quarter, we also exited several positions including InPost S.A. , HD Korea Shipbuilding & Offshore Engineering Co., Ltd. , Kuaishou Technology , Park Systems Corporation , Kaynes Technology India Limited , WuXi Biologics (Cayman) Inc. , and HDFC Bank Limited , as we continue our endeavor to allocate capital to our highest conviction ideas.”
Read the letterWuXi Biologics (Cayman) Inc.
Fund coverage · 1 thesis
- Artisan Sustainable Emerging Markets StrategyDecember 2025
WuXi Biologics (Cayman) Inc. is a leading biologics CDMO with best-in-class capabilities, scale, and innovation that support a favorable long-term outlook despite near-term headwinds.
Read the full thesis
Read every full thesis on WuXi Biologics (Cayman) Inc.
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→